AbbVie Just Won FDA Approval for a Once-Daily Parkinson’s Pill. Here’s Why It Matters More Than You Think.
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think. Yahoo Finance
2026
FDA approves Ponlimsi, a biosimilar for preventing fractures in prostate and breast cancer patients
FDA approves Ponlimsi, a biosimilar for preventing fractures in prostate and breast cancer patients The Cancer Letter
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL OncLive